Takashi Shibata
Fortuna: 6 M $ al 30/06/2026
Fortuna: 6 M $ al 30/06/2026
Takashi Shibata is currently the Chairman of Japan Chlorine Dioxide Industry Association since 2011 and the President & Representative Director of Taiko Pharmaceutical Co., Ltd. since 1998.
He holds a doctorate degree from Kawasaki Medical School, conferred in 1981, and another doctorate degree from Graduate School of Medicine Osaka University, conferred in 1987.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2025 | 3.330.431 ( 6,58 % ) | 6 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TAIKO PHARMACEUTICAL CO.,LTD. | Presidente | 01/06/2010 |
Japan Chlorine Dioxide Industry Association | Presidente | 01/07/2011 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Taiko Pharmaceutical Co., Ltd.
Taiko Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and sale of pharmaceutical products | Health Technology |
Japan Chlorine Dioxide Industry Association | |
Kawasaki Medical School
Kawasaki Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graduate School of Medicine Osaka University
Graduate School of Medicine Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.